Search Results - fu-shin+yu

1 Results

Sort By:

Topical IL-1Ra (anakinra) in the form of gel to treat persistent diabetic skin and corneal wounds

BackgroundAnakinra (aka. Kineret) is a recombinant human IL-1Ra that was developed by Amgen. It is currently used to treat moderately to severely active rheumatoid arthritis, but also treats neonatal-onset multisystem inflammatory disease (NOMID). Anakinra is given as an IV dose and the drug is no longer under patent. The properties of Anakinra are...

Published: 6/13/2025 | Inventor(s): Fu-Shin Yu

Keywords(s):

Category(s): Biologicals, Drug Discovery, Pharmaceuticals, Therapeutics, Life Science